UPDATE: Nomura Raises Price Target On BioMarin Pharmaceutical On Positive Preliminary BMN-190 Data
January 14, 2015 at 07:08 AM EST
In a report published Wednesday, Nomura analyst Ian Somaiya reiterated a Buy rating on BioMarin Pharmaceutical (NASDAQ: BMRN), and ...